Systemic ciclosporin and tacrolimus in dermatology

    Research output: Contribution to journalArticlepeer-review


    Ciclosporin and tacrolimus are calcineurin inhibiting immunosuppressant agents useful in the treatment of immune-mediated inflammatory dermatoses. Available data and clinical experience demonstrate ciclosporin's efficacy in treating psoriasis, atopic dermatitis, pyoderma gangrenosum, lichen planus, autoimmune bullous disease (in combination with corticosteroids), recalcitrant chronic idiopathic urticaria, and chronic dermatitis of the hands and feet. Although the role of topical tacrolimus in atopic dermatitis is well established, such experience with the oral formulation of tacrolimus has been limited. However, there are several case studies and anecdotal reports of the successful use of oral tacrolimus in various dermatoses. In this article we discuss the utility of systemic ciclosporin and tacrolimus in dermatology. © Blackwell Publishing, Inc., 2007.
    Original languageEnglish
    Pages (from-to)239-250
    Number of pages11
    JournalDermatologic Therapy
    Issue number4
    Publication statusPublished - Jul 2007


    • Calcineurin inhibitors
    • Ciclosporin
    • Macrolides
    • Tacrolimus


    Dive into the research topics of 'Systemic ciclosporin and tacrolimus in dermatology'. Together they form a unique fingerprint.

    Cite this